# PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

> **NCT00614705** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 80 (actual)

## Conditions studied

- Neuralgia, Postherpetic

## Interventions

- **DRUG:** PH-797804
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00614705
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614705, "PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00614705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*